Drug Research & Development

Since our founding, Watson has been willing to place our own resources, talent and expertise on the line to develop value-added products that benefit consumers and stockholders alike. Through internal research and development, we make good drugs better, finding ways to deliver them with greater safety, stability and/or effectiveness.

Our technological achievements are possible because of our skillful employee teams, who lend vision and enthusiasm to our continual quest for quality.

In our earliest days as a company, we initially concentrated our internal product development efforts on difficult-to-produce generics in specialty areas that required technology to solve stability issues. Using this strategy, we were able to advance into new market areas and differentiate our products from competitors.

Our investment in internal research and development continues to rise, as we develop line extensions for existing products and original formulations furthered by our proprietary R&D capabilities. Our exceptional R&D teams, both in brand and generic development, represent a formidable knowledge base in such drug delivery technologies as solid dosage, transdermal, and oral transmucosal.

As we chart our path ahead, we remain committed to internal research and development as one of the essential building blocks for our continued evolution.